Talkspace, Inc.

  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: US87427V1035
USD
5.13
-0.01 (-0.19%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryPrice Point
High/Low

1Day

52 Week

Valuation
Technical
Day's Volume

CASH

10.46 M

Shareholding (Dec 2025)

FII

4.10%

Held by 45 FIIs

DII

69.35%

Held by 34 DIIs

Promoter

6.11%

How big is Talkspace, Inc.?

22-Jun-2025

As of Jun 18, Talkspace, Inc. has a market capitalization of 476.85 million and reported net sales of 194.36 million with a net profit of 2.93 million over the latest four quarters. The balance sheet shows shareholder's funds of 117.39 million and total assets of 212.82 million.

As of Jun 18, Talkspace, Inc. has a market capitalization of 476.85 million, classified as a Micro Cap.<BR><BR>As of Jun 18, the company reported net sales of 194.36 million for the latest four quarters and a net profit of 2.93 million during the same period.<BR><BR>As of Dec 24, the balance sheet shows shareholder's funds of 117.39 million and total assets of 212.82 million.

View full answer

What does Talkspace, Inc. do?

22-Jun-2025

Talkspace, Inc. is a micro-cap company in the Pharmaceuticals & Biotechnology industry, with recent net sales of $52 million and a market cap of $476.85 million. It has a P/E ratio of 188.00 and no dividend yield.

Overview:<BR>Talkspace, Inc. operates in the Pharmaceuticals & Biotechnology industry and is classified as a micro-cap company.<BR><BR>Financial Snapshot:<BR>Most recent Net Sales: 52 Million (Quarterly Results - Mar 2025) <BR>Most recent Net Profit: 0 Million (Quarterly Results - Mar 2025) <BR>Market-cap: USD 476.85 Million (Micro Cap)<BR><BR>Key Metrics:<BR>P/E: 188.00 <BR>Dividend Yield: 0.00% <BR>Debt Equity: -0.96 <BR>Return on Equity: 2.59% <BR>Price to Book: 4.20 <BR><BR>Contact Details:<BR>Registrar Address: Not available.

View full answer

Should I buy, sell or hold Talkspace, Inc.?

22-Jun-2025

Is Talkspace, Inc. overvalued or undervalued?

05-Nov-2025

As of October 31, 2025, Talkspace, Inc. is considered overvalued with a high P/E ratio of 188 and negative EV to EBITDA, despite short-term outperformance against the S&P 500, indicating a valuation grade shift from very attractive to attractive.

As of 31 October 2025, the valuation grade for Talkspace, Inc. has moved from very attractive to attractive. The company appears to be overvalued, particularly given its high P/E ratio of 188, which is significantly above the peer average of 156.07, and its negative EV to EBITDA of -170.31, indicating substantial operational challenges. Additionally, the PEG ratio stands at 1.51, suggesting that the stock may not be justified by its growth prospects.<BR><BR>In comparison to its peers, Fulgent Genetics, Inc. has a P/E of -21.28, while Enhabit, Inc. has a P/E of 12.80, both indicating that Talkspace is trading at a premium despite its negative financial metrics. The stock has outperformed the S&P 500 in the short term, with a 3-year return of 429.14% compared to the S&P 500's 76.66%, but it has underperformed over the longer term, with a 5-year return of -65.53% versus the S&P 500's 109.18%. This mixed performance further supports the conclusion that Talkspace is currently overvalued.

View full answer

Is Talkspace, Inc. technically bullish or bearish?

05-Nov-2025

As of October 31, 2025, Talkspace, Inc. exhibits a neutral trend with mixed signals, showing bullish MACD indicators but bearish RSI on the weekly, while outperforming the S&P 500 recently, suggesting caution in a sideways market.

As of 31 October 2025, the technical trend for Talkspace, Inc. has changed from mildly bearish to sideways. The current stance is neutral, with mixed signals across various indicators. The MACD is bullish on both weekly and monthly time frames, while the RSI indicates a bearish signal on the weekly but shows no signal on the monthly. Moving averages are mildly bearish on the daily, and both KST and Bollinger Bands present a bullish signal on the weekly, with Bollinger Bands showing sideways movement on the monthly. Dow Theory indicates no trend in both weekly and monthly periods.<BR><BR>In terms of performance, Talkspace has outperformed the S&P 500 over the past week and month, with returns of 22.71% and 21.38% respectively, but lags behind on a year-to-date and one-year basis. Overall, the mixed signals suggest caution as the stock navigates a sideways trend.

View full answer
iScoreScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

Dashboard

1

With a growth in Operating Profit of 87.46%, the company declared Outstanding results in Dec 25

  • The company has declared positive results for the last 9 consecutive quarters
  • ROCE(HY) Highest at 6.65%
  • NET SALES(Q) Highest at USD 63 MM
  • OPERATING PROFIT(Q) Highest at USD 4.65 MM
2

With ROE of 6.66%, it has a fair valuation with a 7.34 Price to Book Value

3

Market Beating performance in long term as well as near term

stock-summaryMojo Parameters

Mojo Parameters

Stock DNA

stock-summary
Industry

Pharmaceuticals & Biotechnology

stock-summary
Market cap

USD 859 Million (Small Cap)

stock-summary
P/E

110.00

stock-summary
Industry P/E

NA

stock-summary
Dividend Yield

0.00%

stock-summary
Debt Equity

-0.79

stock-summary
Return on Equity

6.66%

stock-summary
Price to Book

7.34

Revenue and Profits:
Net Sales:
63 Million
(Quarterly Results - Dec 2025)
Net Profit:
5 Million
stock-summaryTotal Returns
Total Returns (Price + Dividend) stock-summary
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
40.55%
0%
40.55%
6 Months
92.13%
0%
92.13%
1 Year
78.75%
0%
78.75%
2 Years
43.7%
0%
43.7%
3 Years
616.18%
0%
616.18%
4 Years
200.0%
0%
200.0%
5 Years
-48.6%
0%
-48.6%

Talkspace, Inc. for the last several years.

Risk Adjusted Returns v/s stock-summary
stock-summaryNews & Corporate Actions

News

Icon
No Recent News for the Company

Announcements stock-summary

Icon
No announcement available

Corporate Actions stock-summary

Icon
No corporate action available
stock-summaryKey Factors

Quality key factors stock-summary

Factor
Value
Sales Growth (5y)
60.47%
EBIT Growth (5y)
22.65%
EBIT to Interest (avg)
-19.07
Debt to EBITDA (avg)
Negative Net Debt
Net Debt to Equity (avg)
-0.96
Sales to Capital Employed (avg)
1.59
Tax Ratio
1.74%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
80.17%
ROCE (avg)
0
ROE (avg)
0.65%

Valuation key factors

Factor
Value
P/E Ratio
110
Industry P/E
Price to Book Value
7.34
EV to EBIT
243.08
EV to EBITDA
127.15
EV to Capital Employed
31.36
EV to Sales
3.35
PEG Ratio
0.19
Dividend Yield
NA
ROCE (Latest)
12.90%
ROE (Latest)
6.66%

Technicals key factors

Indicator
Weekly
Monthly
MACD
Bullish
Bullish
RSI
Bearish
No Signal
Bollinger Bands
Mildly Bullish
Bullish
Moving Averages
Bullish (Daily)
KST
Bullish
Bullish
Dow Theory
No Trend
Mildly Bullish
OBV
No Trend
Bullish
stock-summary Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
stock-summaryShareholding
Shareholding Snapshot : Dec 2025stock-summary
Shareholding Compare (%holding) stock-summary
Majority shareholders

Domestic Funds

Domestic Funds

Held in 36 Schemes (20.45%)

Foreign Institutions

Held by 45 Foreign Institutions (4.1%)

Strategic Entities with highest holding

Highest Public shareholder

stock-summaryFinancial
[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - Dec'25 - QoQ",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "QoQ Growth in quarter ended Dec 2025 is 6.06% vs 9.39% in Sep 2025",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "QoQ Growth in quarter ended Dec 2025 is 45.45% vs 760.00% in Sep 2025",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Dec'25",
        "Sep'25",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "63.00",
          "val2": "59.40",
          "chgp": "6.06%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "4.60",
          "val2": "2.90",
          "chgp": "58.62%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Exceptional Items",
          "val1": "-1.50",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "4.80",
          "val2": "3.30",
          "chgp": "45.45%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "60.80%",
          "val2": "37.00%",
          "chgp": "2.38%",
          "chgp_class": "positive"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Dec'25",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Dec 2025 is 22.01% vs 25.07% in Dec 2024",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Dec 2025 is 609.09% vs 105.73% in Dec 2024",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Dec'25",
        "Dec'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "228.90",
          "val2": "187.60",
          "chgp": "22.01%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "6.00",
          "val2": "-3.60",
          "chgp": "266.67%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Exceptional Items",
          "val1": "-1.50",
          "val2": "-0.20",
          "chgp": "-650.00%",
          "chgp_class": "negative"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "7.80",
          "val2": "1.10",
          "chgp": "609.09%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "13.80%",
          "val2": "-24.00%",
          "chgp": "3.78%",
          "chgp_class": "positive"
        }
      ]
    }
  }
]

Quarterly Results Snapshot (Consolidated) - Dec'25 - QoQstock-summary

Dec'25
Sep'25
Change(%)
Net Sales
63.00
59.40
6.06%
Operating Profit (PBDIT) excl Other Income
4.60
2.90
58.62%
Interest
0.00
0.00
Exceptional Items
-1.50
0.00
Consolidate Net Profit
4.80
3.30
45.45%
Operating Profit Margin (Excl OI)
60.80%
37.00%
2.38%
USD in Million.
Direction Arrows
Net Sales

QoQ Growth in quarter ended Dec 2025 is 6.06% vs 9.39% in Sep 2025

Direction Arrows
Consolidated Net Profit

QoQ Growth in quarter ended Dec 2025 is 45.45% vs 760.00% in Sep 2025

Annual Results Snapshot (Consolidated) - Dec'25stock-summary

Dec'25
Dec'24
Change(%)
Net Sales
228.90
187.60
22.01%
Operating Profit (PBDIT) excl Other Income
6.00
-3.60
266.67%
Interest
0.00
0.00
Exceptional Items
-1.50
-0.20
-650.00%
Consolidate Net Profit
7.80
1.10
609.09%
Operating Profit Margin (Excl OI)
13.80%
-24.00%
3.78%
USD in Million.
Direction Arrows
Net Sales

YoY Growth in year ended Dec 2025 is 22.01% vs 25.07% in Dec 2024

Direction Arrows
Consolidated Net Profit

YoY Growth in year ended Dec 2025 is 609.09% vs 105.73% in Dec 2024

stock-summaryCompany CV
About Talkspace, Inc. stock-summary
stock-summary
Talkspace, Inc.
Pharmaceuticals & Biotechnology
No Details Available.
Company Coordinates stock-summary
Icon
No Company Details Available